Lu Wei's 100,000 Tonnes/Year Lactic Acid And Polylactic Acid Project Scheduled To Start This Month 

April 9, Zibo City, Shandong Province, Zichuan District, the first quarter of 2022 key work observation review analysis will be held, the towns, streets, economic development zones since 2022 key work to carry out observation review.

Lu Wei pharmaceutical glucose project, lactic acid polylactic acid project, wastewater treatment and regeneration technology reform project to accept the participants to review.

Glucose deep processing project, lactic acid polylactic acid phase I project

At the site of Lu Wei VC Industrial Park, the participants listened to the progress report of the glucose deep processing project and 100,000 tons/year lactic acid polylactic acid a project. The site of the Lu Wei VC Industrial Park is more than 600 mu, requiring the demolition of 47 enterprises, 17 breeding households, 18 residential houses and nearly 1,000 graves.

After the start of the project, Songling Road Street Office set up a special class for demolition, tackling difficulties, daily scheduling, top promotion, to achieve a comprehensive "zero" ground attachment, Zichuan speed, Zichuan service, Zichuan efficiency brand. The total investment of the two projects is 2.5 billion yuan, after reaching production can achieve a total output value of 16 billion yuan, tax revenue of 900 million yuan.

At present, VC Industrial Park has the site construction conditions, plans to start construction in late April. The participants praised, Lu Wei pharmaceutical 10 years to sharpen a sword, the two city's key projects to start construction, will effectively promote the transformation and upgrading of industrial industries in Zichuan District, Zichuan District, as the city's important growth pole of high-quality development to contribute positive power.

At present, Lu Wei Pharmaceutical Group is seizing the opportunity of domestic and international "double cycle" development, accelerating the cultivation of new industries, lengthening the product chain, VC toothpaste, mask, chewable tablets and other terminal products successfully listed, and foreign companies signed a cooperation agreement on polylactic acid project, and actively build "bigger main business, diversified development "We are striving to build a world-class production base for VC industry and a domestic production base for biodegradable new materials.

In June 2021, Lu Wei Pharmaceutical Group Limited signed a contract with Hong Kong Bovey Chemical Company Limited for a PLA production project.

In October 2021, Shandong K.K. Xiang Bio-technology Co., Ltd. was established with a proposed investment of 1 billion yuan for a new 100,000 tons/year L-lactic acid PLA project. K.K. Shandong Biological and Lu Wei Pharmaceutical belong to the same parent company - Zibo Huaxin International Trade Co.